NYSE$RMD
ResMed Inc · Q3 2021 earnings
Q3 2021 earnings · · Investor relations
Briefing
ResMed's Q3 2021 earnings were announced, revealing comparable revenue but a net loss due to a tax reserve, with growth in specific segments and an optimistic outlook.
ResMed reported comparable revenue of $768.8 million, but experienced a net loss of $78.5 million, or $(0.54) per share, due to a $255 million reserve for a tax dispute with the Australian Tax Office. Excluding COVID-19 revenue from the prior year, revenue increased by 1% on a constant currency basis. Non-GAAP diluted EPS was $1.30. The company is optimistic about future growth, driven by increased awareness of respiratory health and adoption of digital health solutions.
- Revenue was comparable at $768.8 million, but decreased 3% on a constant currency basis.
- GAAP diluted earnings per share was $(0.54), while non-GAAP diluted earnings per share was $1.30.
- A $255 million reserve was taken for a dispute with the Australian Tax Office, impacting net income.
- The company sees accelerated awareness of respiratory health and growing adoption of digital health.
Headline financials
Revenue & EPS history
ResMed · Revenue · Quarterly
$769M
Revenue by segment
ResMed · $675M total across 2 segments · Q3 2021
- Total Devices$366M—54.2%
- Total Masks and other$309M—45.8%
Forward guidance
ResMed anticipates accelerated growth in patient flow and ongoing progress toward improving 250 million lives in out-of-hospital healthcare by 2025.
Tailwinds
- Accelerated awareness of the importance of respiratory health.
- Growing adoption of digital health solutions.
- Increased focus on healthcare delivered at home.
- Confidence in accelerated growth in patient flow.
- Ongoing progress toward improving 250 million lives in out-of-hospital healthcare by 2025.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q3 2021
+0.1%
Avg return
Earnings day
+0.7%
Avg return
5 days after
+1.2%
Avg return
30 days after
49%
33 / 67 earnings
Positive
+18.7%
Q3 2024
Best reaction
-19.3%
Q2 2019
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q3 2026 | -2.9% | -2.0% | -10.8% | |
| Q2 2026 | -1.5% | +2.1% | -0.5% | |
| Q1 2026 | -1.5% | -2.8% | +1.4% | |
| Q3 2025 | +10.1% | +10.9% | +13.2% | |
| Q2 2025 | -8.3% | -5.8% | -9.4% | |
| Q1 2025 | +7.9% | +2.9% | +2.7% | |
| Q4 2024 | +4.9% | +2.6% | +14.9% | |
| Q3 2024 | +18.7% | +16.4% | +16.0% | |
| Q2 2024 | +6.5% | +9.3% | +5.2% | |
| Q1 2024 | -4.2% | +0.5% | +9.5% | |
| Q4 2023 | -19.3% | -19.3% | -28.3% | |
| Q3 2023 | +7.6% | +5.4% | -3.8% | |
| Q2 2023 | -2.8% | -1.2% | -8.5% | |
| Q1 2023 | -6.5% | -5.6% | -1.7% | |
| Q4 2022 | -1.5% | -3.1% | -3.1% | |
| Q3 2022 | -6.9% | -8.5% | -3.0% | |
| Q2 2022 | -6.5% | +0.5% | +6.2% | |
| Q1 2022 | -1.9% | -2.1% | -6.3% | |
| Q4 2021 | +0.5% | +0.7% | +8.3% | |
| Q3 2021 | -10.6% | -8.6% | -2.0% | |
| Q2 2021 | -5.8% | -3.5% | -9.9% | |
| Q1 2021 | +6.2% | +12.1% | +16.0% | |
| Q4 2020 | -13.4% | -13.6% | -14.4% | |
| Q3 2020 | +1.8% | +2.0% | +2.9% | |
| Q2 2020 | -4.1% | +0.6% | -4.1% | |
| Q1 2020 | +13.8% | +15.7% | +14.6% | |
| Q4 2019 | +1.1% | +3.8% | +5.4% | |
| Q3 2019 | +7.9% | +7.6% | +9.3% | |
| Q2 2019 | -19.3% | -21.5% | -13.6% | |
| Q1 2019 | +6.2% | +7.3% | +5.7% | |
| Q4 2018 | -2.1% | +0.7% | +4.1% | |
| Q3 2018 | -2.1% | -1.4% | +6.9% | |
| Q2 2018 | +13.2% | +15.9% | +5.1% | |
| Q1 2018 | +7.7% | +7.4% | +8.6% | |
| Q4 2017 | -6.0% | -2.6% | +0.6% | |
| Q3 2017 | -5.2% | -2.7% | -2.3% | |
| Q2 2017 | +9.5% | +7.1% | +13.7% | |
| Q1 2017 | -5.0% | -5.3% | -8.7% | |
| Q4 2016 | +5.8% | +6.5% | +6.0% | |
| Q3 2016 | -7.4% | — | — | |
| Q2 2016 | +7.1% | — | — | |
| Q1 2016 | +0.1% | — | — | |
| Q4 2015 | +3.6% | — | — | |
| Q3 2015 | -10.3% | — | — | |
| Q2 2015 | +8.6% | — | — | |
| Q1 2015 | +9.5% | — | — | |
| Q4 2014 | -4.1% | — | — | |
| Q3 2014 | -0.4% | — | — | |
| Q2 2014 | -5.7% | — | — | |
| Q1 2014 | -13.2% | — | — | |
| Q4 2013 | +0.5% | — | — | |
| Q3 2013 | +0.9% | — | — | |
| Q2 2013 | +7.0% | — | — | |
| Q1 2013 | -4.7% | — | — | |
| Q4 2012 | +12.8% | — | — | |
| Q3 2012 | +7.6% | — | — | |
| Q2 2012 | +9.7% | — | — | |
| Q1 2012 | -12.0% | — | — | |
| Q4 2009 | -5.4% | — | — | |
| Q4 2011 | -5.4% | — | — | |
| Q3 2011 | -0.9% | — | — | |
| Q3 2010 | -0.9% | — | — | |
| Q2 2010 | +2.2% | — | — | |
| Q2 2011 | +2.2% | — | — | |
| Q1 2010 | +3.6% | — | — | |
| Q1 2011 | +3.6% | — | — | |
| Q4 2010 | +3.6% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro